Transactions
UNDISCLOSED
Exclusive Financial Advisor
Merger with ARS Pharmaceuticals
Pending
$100 Million
Joint Bookrunner
Follow-On and Concurrent Private Placement
July 2022
Up to $475 Million
Financial Advisor
Strategic Alliance / Option-to-Acquire with Abbvie
July 2022
UNDISCLOSED
Exclusive Financial Advisor
Strategic Capital Investment from Court Square Capital Partners
July 2022
$94 Million
Joint Bookrunner
Follow-On
June 2022
$1.875 Billion
Lead Financial Advisor
Sale
Pending
$30 Million
Sole Bookrunner
Follow-On
June 2022
$250 Million
Joint Bookrunner
Follow-On
June 2022
$28 Million
Exclusive Financial Advisor
Series C Financing Led by MultiPlan Corporation
June 2022
$112 Million
Joint Bookrunner
Follow-On
June 2022
$20 Million
Financial Advisor
Private Placement
June 2022
$30 Million
Joint Bookrunner
Follow-On
June 2022